Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-19-061049

EVP, General Counsel sold 78,000 shares at $125.50 ($9,789,000)

  • EVP, General Counsel acquired 78,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Howton David T · EVP, General Counsel

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-12-13 Exercise or conversion : show line 1 in the form +18,579 $13.90 $258,248 43,750 D
2019-12-13 Exercise or conversion : show line 2 in the form +59,421 $23.85 $1,417,191 103,171 D
2019-12-13 Sale : show line 3 in the form −78,000 $125.50 $9,789,000 25,171 D
Open-market sales · 78,000 sh · avg $125.50 · $9,789,000

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-12-13 Exercise or conversion : show line 4 in the form Stock option (right to buy) −18,579 $13.90 2025-02-27 18,579 0 D
2019-12-13 Exercise or conversion : show line 5 in the form Stock option (right to buy) −59,421 $23.85 2022-11-05 59,421 56,984 D
Loading xslF345X03/doc4.xml…